FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312065239> ?p ?o ?g. }

• W4312065239 endingPage "484" @default.
• W4312065239 startingPage "473" @default.
• W4312065239 abstract "In patients with acute myocardial infarction (MI) and multivessel coronary artery disease, percutaneous coronary intervention (PCI) of non-infarct-related artery reduces death or MI. However, whether selective PCI guided by fractional flow reserve (FFR) is superior to routine PCI guided by angiography alone is unclear. The current trial sought to compare FFR-guided PCI with angiography-guided PCI for non-infarct-related artery lesions among patients with acute MI and multivessel disease.Patients with acute MI and multivessel coronary artery disease who had undergone successful PCI of the infarct-related artery were randomly assigned to either FFR-guided PCI (FFR ≤0.80) or angiography-guided PCI (diameter stenosis of >50%) for non-infarct-related artery lesions. The primary end point was a composite of time to death, MI, or repeat revascularization. A total of 562 patients underwent randomization. Among them, 60.0% underwent immediate PCI for non-infarct-related artery lesions and 40.0% were treated by a staged procedure during the same hospitalization. PCI was performed for non-infarct-related artery in 64.1% in the FFR-guided PCI group and 97.1% in the angiography-guided PCI group, and resulted in significantly fewer stent used in the FFR-guided PCI group (2.2 ± 1.1 vs. 2.5 ± 0.9, P < 0.001). At a median follow-up of 3.5 years (interquartile range: 2.7-4.1 years), the primary end point occurred in 18 patients of 284 patients in the FFR-guided PCI group and in 40 of 278 patients in the angiography-guided PCI group (7.4% vs. 19.7%; hazard ratio, 0.43; 95% confidence interval, 0.25-0.75; P = 0.003). The death occurred in five patients (2.1%) in the FFR-guided PCI group and in 16 patients (8.5%) in the angiography-guided PCI group; MI in seven (2.5%) and 21 (8.9%), respectively; and unplanned revascularization in 10 (4.3%) and 16 (9.0%), respectively.In patients with acute MI and multivessel coronary artery disease, a strategy of selective PCI using FFR-guided decision-making was superior to a strategy of routine PCI based on angiographic diameter stenosis for treatment of non-infarct-related artery lesions regarding the risk of death, MI, or repeat revascularization." @default.
• W4312065239 created "2023-01-04" @default.
• W4312065239 creator A5003620021 @default.
• W4312065239 creator A5009622965 @default.
• W4312065239 creator A5010334767 @default.
• W4312065239 creator A5010403844 @default.
• W4312065239 creator A5010736960 @default.
• W4312065239 creator A5012918239 @default.
• W4312065239 creator A5013017147 @default.
• W4312065239 creator A5014017983 @default.
• W4312065239 creator A5016955448 @default.
• W4312065239 creator A5020870005 @default.
• W4312065239 creator A5020991381 @default.
• W4312065239 creator A5025828391 @default.
• W4312065239 creator A5026332399 @default.
• W4312065239 creator A5034107357 @default.
• W4312065239 creator A5034891717 @default.
• W4312065239 creator A5035456738 @default.
• W4312065239 creator A5035609155 @default.
• W4312065239 creator A5045678305 @default.
• W4312065239 creator A5048071774 @default.
• W4312065239 creator A5048220648 @default.
• W4312065239 creator A5049290277 @default.
• W4312065239 creator A5070187732 @default.
• W4312065239 creator A5072679935 @default.
• W4312065239 creator A5073009003 @default.
• W4312065239 creator A5076220229 @default.
• W4312065239 creator A5079503932 @default.
• W4312065239 creator A5083595044 @default.
• W4312065239 creator A5087463011 @default.
• W4312065239 creator A5090549649 @default.
• W4312065239 date "2022-12-20" @default.
• W4312065239 modified "2023-10-18" @default.
• W4312065239 title "Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial" @default.
• W4312065239 cites W1937493121 @default.
• W4312065239 cites W1995734689 @default.
• W4312065239 cites W2008103786 @default.
• W4312065239 cites W2132861593 @default.
• W4312065239 cites W2161812533 @default.
• W4312065239 cites W2166538393 @default.
• W4312065239 cites W2167425511 @default.
• W4312065239 cites W2210592417 @default.
• W4312065239 cites W2266436320 @default.
• W4312065239 cites W2331820709 @default.
• W4312065239 cites W2508848908 @default.
• W4312065239 cites W2595039702 @default.
• W4312065239 cites W2744283407 @default.
• W4312065239 cites W2753505755 @default.
• W4312065239 cites W2794472321 @default.
• W4312065239 cites W2896913724 @default.
• W4312065239 cites W2906838549 @default.
• W4312065239 cites W2916912835 @default.
• W4312065239 cites W2970909790 @default.
• W4312065239 cites W3025215080 @default.
• W4312065239 cites W3026367181 @default.
• W4312065239 cites W3028312329 @default.
• W4312065239 cites W3046900279 @default.
• W4312065239 cites W3162195278 @default.
• W4312065239 cites W3163922783 @default.
• W4312065239 cites W3196085633 @default.
• W4312065239 cites W4292856638 @default.
• W4312065239 doi "https://doi.org/10.1093/eurheartj/ehac763" @default.
• W4312065239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36540034" @default.
• W4312065239 hasPublicationYear "2022" @default.
• W4312065239 type Work @default.
• W4312065239 citedByCount "21" @default.
• W4312065239 countsByYear W43120652392023 @default.
• W4312065239 crossrefType "journal-article" @default.
• W4312065239 hasAuthorship W4312065239A5003620021 @default.
• W4312065239 hasAuthorship W4312065239A5009622965 @default.
• W4312065239 hasAuthorship W4312065239A5010334767 @default.
• W4312065239 hasAuthorship W4312065239A5010403844 @default.
• W4312065239 hasAuthorship W4312065239A5010736960 @default.
• W4312065239 hasAuthorship W4312065239A5012918239 @default.
• W4312065239 hasAuthorship W4312065239A5013017147 @default.
• W4312065239 hasAuthorship W4312065239A5014017983 @default.
• W4312065239 hasAuthorship W4312065239A5016955448 @default.
• W4312065239 hasAuthorship W4312065239A5020870005 @default.
• W4312065239 hasAuthorship W4312065239A5020991381 @default.
• W4312065239 hasAuthorship W4312065239A5025828391 @default.
• W4312065239 hasAuthorship W4312065239A5026332399 @default.
• W4312065239 hasAuthorship W4312065239A5034107357 @default.
• W4312065239 hasAuthorship W4312065239A5034891717 @default.
• W4312065239 hasAuthorship W4312065239A5035456738 @default.
• W4312065239 hasAuthorship W4312065239A5035609155 @default.
• W4312065239 hasAuthorship W4312065239A5045678305 @default.
• W4312065239 hasAuthorship W4312065239A5048071774 @default.
• W4312065239 hasAuthorship W4312065239A5048220648 @default.
• W4312065239 hasAuthorship W4312065239A5049290277 @default.
• W4312065239 hasAuthorship W4312065239A5070187732 @default.
• W4312065239 hasAuthorship W4312065239A5072679935 @default.
• W4312065239 hasAuthorship W4312065239A5073009003 @default.
• W4312065239 hasAuthorship W4312065239A5076220229 @default.
• W4312065239 hasAuthorship W4312065239A5079503932 @default.
• W4312065239 hasAuthorship W4312065239A5083595044 @default.
• W4312065239 hasAuthorship W4312065239A5087463011 @default.
• W4312065239 hasAuthorship W4312065239A5090549649 @default.
• W4312065239 hasConcept C119060515 @default.

• next